Global
Health and Humanitarianism Delivered March
28, 2000 by Joelle Tanguy, U.S. Executive Director,
MSF, at Stanford
University
Good Afternoon,
It is a great pleasure for me to be here at Stanford
University, especially here at the Business School. That’s where I
started the oddest carrier path in the MBA class of '82, from the
Silicon Valley to Doctors Without Borders. I left the Bay area after
engineering a sabbatical leave from my software product management
job and volunteered with Doctors Without Borders, more than 10 years
ago. It’s great to be back here, meet old friends, rediscover the
campus, the new GSB building—it has changed so much!—and reach out
to you!
VOLUNTEERING
I started with Doctors Without Borders after the
Armenian earthquake of December 1988. It was supposed to be a short
volunteer assignment. Some temporary parenthesis in a busy life. But
I eventually found myself living five consecutive years of a nomad
life—with nothing but a blue sports bag to hold my possessions—from
crisis to crisis. From Armenia to Uganda, from Zaire to Somalia,
from Sierra Leone to Bosnia.
I was not a caregiver, since they don’t teach basic
medical skills at Stanford Business School, but I progressively came
to enroll the support of medical volunteers and coordinators, and I
came to direct emergency and refugee operations involving primary
health care support, acute nutrition programs, epidemics control,
refugee assistance and war surgery, often amidst political turmoil.
I made friends of all cultures around the world, from the ruins of
Armenia to the war-torn streets of Mogadishu. It had become my life;
it was the best I could have ever dreamt: it reconciled my soul with
my work, my values with my personal challenges.
Everyone volunteers initially for a different
reason. It can be the search for new challenges or new meaning, or
the accomplishment of an old dream, or the need to serve, or the
appeal of traveling, of meeting new faces, of feeling part of the
planet's humanity.
One of my Argentinean colleagues once said something
that really made sense to me. He said, " I am not trying to do
anything cosmic, like saving the world. I believe one can help with
little steps, a small grain here, a small grain there". This is so
true, every single person you help, every life you save, every
suffering you alleviate, makes the trip worthwhile. And it's
important that they'd be people willing to travel 6000 miles from
their homes to tie bandages, it's important because it shows respect
for life and humanity, without discrimination. You live for yourself
and you discover other people in the process.
The grand ideas and the altruistic but distant
feelings for that other half of humanity that we might have before
we leave are completely transformed by working in the field. You
develop a sense of proximity and solidarity to those who suffer on
this other side of earth, now your neighbor, and thrive on the
challenges you have to face to bring relief to the most endangered,
the most destitute. Landing a relief plane in Eastern Congo can be
an even sweeter victory than a wildly successful IPO! And being
deprived of first-world comfort can be taxing but it can also raise
a hot shower to the level of an ecstatic experience!
You also have a new fire within yourself: outrage
and a sense of urgency.
For example, as a volunteer you would see the
devastating injuries to children from landmines. When there's more,
when you’ll see the "made in USA" stamp on them, you’ll be ashamed
and outraged, and you'll be a campaigner to ban landmine all your
life, when you return to your family medical practice or your
business in San Francisco or Oakland!
So let me make a first pitch right here: As of May
24, 1999, the Mine Ban Treaty had been signed by 135 countries, and
ratified by 81 nations. In the Americas, only the United States and
Cuba have not signed the Treaty. The other recalcitrant nations,
including Russia, China, Iraq, and Iran, continue to hide under the
shadow of the non-signature of the United States. It is crucial to
the effort to universalize the ban on landmines, and I invite you
all to support the organizations pressing the U.S. government to
shift its current position and to agree to join the Mine Ban Treaty
now!
Since we’re transitioning from the personal to the
global, I want to bring our conversation to a different plane. First
having a look at global health, focusing on access to essential
medicine, and moving on to the challenges in civil wars and the
state of humanitarianism.
DISEASES WITHOUT BORDERS
When Médecins Sans Frontières was established almost
30 years ago, the medical community was setting for itself the
ambitious goal of the eradication of disease and the rise of life
expectancy worldwide. "Health for All, 2000" was the slogan by the
end of the seventies, when humanity was triumphantly announcing the
eradication of smallpox.
Similarly, the optimism was pervasive in economics
and development circles, and in the Bretton Woods institutions
claiming that sound economic modernization would improve health
status in developing nations.
These ideologies did not pass the test of time.
Instead we must realize that while the gap between the have and the
have-nots is expending rapidly, we also re-entered the era of
"disease without borders". That’s how Laurie Garrett chose to label
our new era where "every day one million people cross an
international border, and as people move, unwanted microbial
hitchhikers tag along. Geographic sequestration was crucial in all
post-war health planning, but diseases can no longer be expected to
remain in their country or region of origin. Even before commercial
air travel, swine flu in 1918-19 managed to circumnavigate the
planet five times in 18 months, killing 22 million people, 500,000
in the United States. How many more victims could a similarly lethal
strain of influenza claim [now], when some half a billion passengers
[a year] board airline flights?"1
The reemergence of infectious disease and the growth
of scope of the refugee crisis, are two lethal factors whose
combination were well portrayed by the cholera crisis in the Rwandan
refugee camps and to some extent by the Ebola and Marburgh scares in
recent years. But another factor, changing the profile of the
challenges awaiting international medical teams, is the growth of
the urban population worldwide. Whereas 23 million people were
displaced in 1994 by social unrest or war, another 30 million moved
from rural to urban areas within their own country. There are new
tremendous challenges lying in the actual heart of the developing
world’s exploding cities.
By 2025 more than 5 billion people, i.e. 61% of the
world’s population will be living in cities2.
Meanwhile, from Cairo to the Bronx, from Kinshasa to Moscow, public
health systems are collapsing under the new influx in population, in
particular the primary health-care system, which is the most
important gateway for the control of infectious diseases. From
onchocercosis to TB, from Guinea worm to Yellow Fever, from Polio to
AIDS, it is striking to realize none of us believes anymore in
inevitable eradication process as we did 10 years ago, and instead
see the challenge is ahead.
And there are serious obstacles on the way. Some of
them lie right here, in our backyard! The policies of US drug
manufacturers so far translate directly into a deadly diagnostic for
millions of people, enunciated as " you’re dying of market failure".
Let me explain.
YOU’RE DYING OF MARKET FAILURE
Treatable communicable diseases such as
tuberculosis, meningitis, and pneumonia are still the leading causes
of death in the developing world.3
In fact more than 90% of all death and suffering from infectious
diseases occurs in the developing world.
Millions are dying because of several reasons—lack
of research and development for neglected diseases, and lack of
access to lifesaving medicines for known diseases.
LACK OF RESEARCH
Research for neglected diseases has ground to a
virtual halt. Little research is being carried out on tropical and
other infectious diseases like malaria and sleeping sickness that
largely affect people in poor nations, because drugs for such
illnesses are not profitable for pharmaceutical companies. Out of
1,223 new drugs brought onto the market worldwide between 1975 and
1997, only 13 were for tropical diseases.
Access to medicines for these communicable diseases
is critical, infectious diseases kill 17 million people a year and
in Africa for example, infectious diseases account for more than 60%
of the deaths. Yet, there is no money for research as research
dollars focus on the lucrative lifestyle drugs for the profitable
developed world markets.4
LACK OF ACCESS TO LIFESAVING MEDICINES
Even when effective treatments exist, as they do for
diseases like multidrug-resistant tuberculosis and many AIDS-related
infections, when lifesaving medicines are available, they are simply
too expensive, due in large part to patent protection and pricing
strategies aligning on the wealthiest markets. A lucrative market
for lifesaving drugs addressing infectious diseases simply does not
exist in the developing world despite the fact that more than 90
percent of all deaths and suffering from infectious diseases occurs
there.
In summary, "Our patients are dying, not because
their diseases are incurable, but because as consumers, they do not
provide a viable market for pharmaceutical products. Clearly, market
forces alone are not enough to address the need for affordable
medicines or to stimulate research and development for neglected
diseases. This market failure is our new challenge."5
Our intuition was that progress would come from a
confluence of efforts: public mobilization, public-private
partnerships and regulation. Two years ago, at Doctors without
Borders, we initiated a campaign to develop "Access to Essential
Medicine", partnering with activists groups, academics,
philanthropic institutions, corporate interest groups (drug
manufacturers and associations), the media and governmental
institutions such as the World Bank to stimulate development and
appropriate pricing of drugs for the developing world. Together we
must ensure that trade of essential medicines is regulated in the
interest of public health. We are not questioning the importance of
patents in stimulating research and development, but rather we are
insisting that a balance be found between protecting intellectual
property and ensuring individuals’ access to medicines. And we are
seeking to provide an impetus for both policy development and
practical solutions to specific access problems.
The progress is very encouraging. In civil society
circles, activist movements have taken on the cause. Academics and
economists such as Jeffrey Sachs have registered the urgency and
scope of the problem and are brainstorming for solutions. On the
political spectrum, Al Gore and Bill Clinton, after having erred
with policies that supported the US Trade Representatives bully of
developing world governments on behalf of US pharmaceutical
companies, turned the official US policy around. On the corporate
horizon, a few drug companies are finally moving forward towards
practical, responsible partnership, finally freed from regressive
rhetoric. We are not far enough yet, and we could use all the help
to convince such firms as Pfizer and Bristol Myers Squibb that to
price out of live saving medicines entire generations of men and
women around the world is neither more nor better business in the
short and in the long run. But at least, with a few, we’re beyond
good PR for charitable donations, we’re entering at last—and
hopefully for good—the realm of corporate responsibility. What the
world essentially needs now is not so much more charity as more
responsibility for structural change.
WAR ZONES: UNCIVIL CIVIL WARS
Most of these public health crises, where Doctors
Without Borders operate, occur in poor countries. When I say poor, I
never know how my Silicon Valley friends understand it. The frame of
reference here is so warped. Did you know that the wealth of the
world’s 3 richest individuals is greater than the combined GDP of
the 48 poorest countries, a quarter of the states on the planet?
That among the 100 largest economies in the world, 5
are corporations, not countries? That 3 billion people—half of the
planet—live on less than 2 dollars a day? That many mothers in
stable but poor areas of the planet can only feed their children
erratically, sometimes only two, three meals a week, and the rest of
the time have the children would suck sugar cane or whatever could
help alleviate hunger?
It is in these same poor countries that the most
uncivil civil wars are being waged. Sometimes rich in natural
resources, always rich in culture, these countries have failed in
the modern political economy. Failed redistribution, failed
accountability and the cycles of exclusion, denial of rights, and
aggression escalate.
In a world where conflicts have less to do with
territory than with economic control and identity of a nation,
civilians have become both pawns and targets for the
belligerents.
Our volunteers are witness to the fact that the toll
on civilians is extraordinary. In 1990, civilians represented 90% of
war casualties, almost half of them children. Civilians have become
the prime targets of opportunistic violence, raiding, looting by
militias and military troops. Even worse, they have become strategic
stakes in these wars. Forced displacement, sieges, starvation,
indiscriminate bombing, massacres and even maiming campaigns and
rape, have become frequent tools of war.
Forty million people are displaced by conflicts,
most of them resourceless and traumatized. Eighty percent of them
are women and children. Displacement easily leads to 30 fold
increases in mortality. The children under 5 are the first to die.
Their elders, if they stay alive, are often stripped of their
dignity and rights. Surviving on humanitarian assistance is no great
solution. In public health terms, being a refugee in a camp, being
dependent of food aid, is a most precarious condition that often
leads to excess mortality and morbidity. In human terms it’s
unbearable. Some of our patients, children and adults alike, the
most traumatized, cannot face their fate, cannot even ask for help,
cannot even receive help, they sit and stare and let themselves
die.
ON HUMANITARIANISM AND MSF
Humanitarianism occurs where political processes
have failed or are in crisis, leading to such situations as war,
community violence, or the marginalization of a minority group. Our
task is the short-term relief of the suffering caused by political
failure seeking out the most vulnerable first. It is an impartial
act out of human solidarity provided on the basis of need alone,
regardless of ethnic origin, gender, creed or political
affiliation.
The Nobel Peace Prize Committee singled out the work
of Doctors Without Borders/Médecins Sans Frontières not only for its
relief operations but also for its will to bear witness, call public
attention to humanitarian catastrophes and point to the causes of
such disasters thus helping form bodies of opinion opposed to
violations and abuses of power.
This is an essential, defining feature of the
organization, grounded in its birth in the Biafra crisis. We have a
commitment bear witness for massive violations of human rights and
humanitarian law. We espouse a new concept of vocal impartiality,
definitely taking distance from the humanitarian dogma on neutrality
that made the Red Cross a silent witness of the Holocaust.
Keeping frontlines and militia checkpoints open to
relief teams to operate on all sides of the conflict while bearing
witness when aid is no longer enough is a challenging exercise. To
ensure our capacity to do so we had to secure total independence
from political, economic and other interfering agendas. To maintain
its independence from political interference, Médecins Sans
Frontières built, worldwide, a pool of individual and private
supporters who guarantee that the majority of the organization’s
funds is independent of governments and other organized interests.
This private funding also gives us the freedom to respond to the
greatest needs as fast as possible.
We are hard-pressed to make sure that in this
confusing and unkind world, at least humanitarian teams can reach
populations in danger, assess independently the needs, deploy
assistance impartially, and monitor the impact of their work to make
sure it helps the most vulnerable. That’s what we call ensuring
"humanitarian space" at the heart of the conflicts.
At the beginning, the organization was just a couple
of doctors, a suitcase and a dream. Today it is the largest private
emergency medical organization by the sheer size of its operations,
number of its volunteers, presence worldwide. We’ve built hundreds
of guidelines, conceived protocols of intervention, worked with the
best of the world’s epidemiologists to certify the quality of our
work, trained thousands of volunteers. We’ve had to deal with
political, military, economic realities and technical challenges
that stretch our capacities in a renewed fashion at every major
crisis. But we’ve refused the temptation of hyper professionalism.
Our actions are and will still be carried out by volunteers. Trained
volunteers yes, qualified doctors and nurses, supervised by a cadre
of experts, but still, at heart, volunteers. They help us question
again and again and revisit anew the old ethical debates.
"Our volunteers and staff live and work among people
whose dignity is violated every day. These volunteers choose freely
to use their liberty to make the world a more bearable place.
Despite grand debates on world order, the act of humanitarianism
comes down to one thing: individual human beings reaching out to
those others who find themselves in the most difficult
circumstances. And they reach out one bandage at a time, one suture
at a time, and one vaccination at a time. And for Médecins Sans
Frontières/Doctors Without Borders, this means also telling the
world of the injustice that they have seen. All this, in the hope
that the cycles of violence and destruction will not continue
endlessly.6
Ethics and humanity are of the essence, and there is
no guideline, no textbook for this. It is a fragile group dynamic
that needs to be sustained daily. That’s what will keep the
humanitarian movement alive.
That’s where the human adventure is too.

- Laurie Garrett, The Coming Plague.
- Source: United Nations
- 90% of death and suffering from infectious
diseases occur in the developing world where there are no local
resources nor lucrative markets to attract them. Infectious
diseases kill 17 million people a year. In Africa, infectious
diseases account for 60% of all deaths
- A single of these neglected diseases, Sleeping
Sickness, alone threatens 60 million people. As ins the case with
many tropical diseases, research targeting this diseases halted
after the de-colonization.
- See Nobel Peace Prize address, James Orbinski,
MSF
- i.d.
|